---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-019906"
form_type: "8-K"
ticker: "APRE"
cik: "0001781983"
company_name: "Aprea Therapeutics, Inc."
filed_at: "2023-02-14T23:59:59+00:00"
generated_at: "2026-06-19T14:17:24.212465+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Aprea Therapeutics completes 1-for-20 reverse stock split; Nasdaq halt through Feb 14

## Summary
- Reverse stock split 1-for-20 effective 5:00 p.m. ET on Feb 10, 2023.
- Nasdaq halted trading in APRE at 7:50 p.m. Feb 10 pending material news related to split.
- Halt is administrative; trading expected to resume at 9:45 a.m. on Feb 14, 2023.

## SEC filing metadata
- accession: 0001104659-23-019906
- form_type: 8-K
- ticker: APRE
- cik: 0001781983
- company_name: Aprea Therapeutics, Inc.
- filed_at: 2023-02-14T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1781983/000110465923019906/0001104659-23-019906-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1781983/000110465923019906/tm236659d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-019906
- JSON: https://secwatch.observer/filing/0001104659-23-019906.json
- Plain text: https://secwatch.observer/filing/0001104659-23-019906.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.